本页面由Tiger Trade Technology Pte. Ltd.提供服务

Revolution Medicines, Inc.

203.77
+0.42000.21%
盘后203.770.00000.00%19:51 EDT
成交量:137.87万
成交额:2.79亿
市值:436.75亿
市盈率:-22.84
高:206.36
开:204.98
低:197.81
收:203.35
52周最高:224.31
52周最低:42.18
股本:2.14亿
流通股本:1.85亿
量比:1.07
换手率:0.75%
股息:- -
股息率:- -
每股收益(TTM):-8.9212
每股收益(LYR):-5.9502
净资产收益率:-79.09%
总资产收益率:-30.12%
市净率:16.76
市盈率(LYR):-34.25

数据加载中...

2025/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/26

重要事件披露

Form 8-K - Current report
2025/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/26

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/05

重要事件披露

Form 8-K - Current report
2024/12/04

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/12/02

重要事件披露

Form 8-K - Current report
2024/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/08

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/06

重要事件披露

Form 8-K - Current report